16 results match your criteria: "IMS Sapporo Digestive Disease Center General Hospital[Affiliation]"
Oncoimmunology
December 2024
Department of Pathology, Sapporo Medical University, Sapporo, Japan.
Neoantigen-reactive CD4 T cells play a key role in the anti-tumor immune response. However, the majority of epithelial tumors are negative for HLA class II (HLA-II) surface expression, and less is known about the processing of HLA-II antigens. Here, we directly identified naturally presented HLA-II neoantigens in HLA-II negative colorectal cancer (CRC) tissue using a proteogenomic approach.
View Article and Find Full Text PDFSci Adv
September 2024
Department of Pathology, Sapporo Medical University, Sapporo, Japan.
Neoantigens arising from somatic mutations are tumor specific and induce antitumor host T cell responses. However, their sequences are individual specific and need to be identified for each patient for therapeutic applications. Here, we present a proteogenomic approach for neoantigen identification, named Neoantigen Selection using a Surrogate Immunopeptidome (NESSIE).
View Article and Find Full Text PDFAnn Surg
July 2024
Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
Objective: This study aimed to clarify the molecular mechanism of remnant pancreatic cancer (PC) development after primary PC resection.
Summary Background Data: Molecular mechanisms of the development of remnant PCs following primary PC resection are largely unknown.
Methods: Forty-three patients undergoing remnant PC resection after primary PC resection between 2001 and 2017 at 26 institutes were retrospectively analyzed.
J Dig Dis
May 2024
Center for Gastroenterology, Teine-Keijinkai Hospital, Sapporo, Hokkaido, Japan.
Objectives: Unresectable ampullary cancer (AC) is a rare disease entity. The risk factors for recurrent biliary obstruction (RBO) following endoscopic biliary stenting (EBS) for unresectable AC remain unknown. In this study we aimed to evaluate the cumulative RBO rate and to identify risk factors for RBO following palliative EBS in patients with unresectable AC.
View Article and Find Full Text PDFClin Gastroenterol Hepatol
July 2024
Department of Surgery, Kansai Medical University, Hirakata, Japan.
Stud Health Technol Inform
January 2024
IMS Sapporo Digestive Disease Center General Hospital, Japan.
The purpose of this study was to evaluate the accuracy of Japanese fill-in-the-blank questions in the radiological technology field using six BERT models. Our original model, created using 330,000 abstracts related to radiological technology, was as accurate as other models created by Wikipedia when vocabulary size was the same. Further improvements in accuracy can be expected if we can increase the vocabulary size and add Japanese Wikipedia data in training.
View Article and Find Full Text PDFNihon Shokakibyo Gakkai Zasshi
May 2023
Division of Gastroenterology, Department of Internal Medicine, IMS Sapporo Digestive Disease Center General Hospital.
An 87-year-old man visited his previous doctor because of jaundice, abdominal pain, and disturbance of consciousness. He was diagnosed with cholangitis and panperitonitis and was referred to our hospital. Emergency laparotomy revealed biliary peritonitis.
View Article and Find Full Text PDFBMC Cancer
December 2022
Division of Cancer Center, Hokkaido University Hospital, Sapporo, Japan.
Background: Although initial therapy with a parenteral anticoagulant is required before edoxaban, this strategy is frequently avoided in actual clinical practice because of its complexity. This study assessed the feasibility of edoxaban without initial heparin usage for asymptomatic cancer-associated thrombosis (CAT) in Japanese patients with gastrointestinal cancer (GIC) at high risk of bleeding.
Methods: In this multicenter prospective feasibility study conducted at 10 Japanese institutions, patients with active GIC who developed accidental asymptomatic CAT during chemotherapy were recruited.
Cancer
March 2023
Department of Surgery, Kindai University Faculty of Medicine, Osaka, Japan.
Background: Based on the Japan Adjuvant Study Group of Pancreatic Cancer 01 study, the standard duration of adjuvant chemotherapy with S-1 (an oral 5-fluorouracil prodrug consisting of tegafur, gimeracil, and oteracil) in patients with resected pancreatic ductal adenocarcinoma (PDAC) was considered to be 6 months, but the impact of increasing its duration on postoperative survival was unknown. Here, the authors investigated this question by reviewing real-world data from a large cohort of patients with PDAC.
Methods: In total, 3949 patients who underwent surgery for PDAC during the study period followed by S-1 adjuvant chemotherapy in board-certified institutions were included.
Cancers (Basel)
October 2022
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.
Background: Systemic treatments are recommended for advanced hepatocellular carcinoma (HCC) in preserved liver function. However, their effects are unsatisfactory in some tumor conditions, particularly macrovascular invasion (MVI) including major portal vein tumor thrombus (PVTT). We compared the efficacy of hepatic arterial infusion chemotherapy (HAIC) regimens New-FP and sorafenib for various tumor conditions in preserved liver function.
View Article and Find Full Text PDFBMJ Open
July 2021
Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan.
Introduction: Neoadjuvant chemotherapy or neoadjuvant chemoradiotherapy (NAC/NACRT) for resectable/borderline resectable pancreatic cancers was recently performed to improve clinical outcomes and led to good results, although it remains controversial whether NAC/NACRT is beneficial for resectable pancreatic cancer. A few recent studies revealed longer patency and lower cost related to the stent occlusion of a metal stent than those of a plastic stent during NAC/NACRT. It also remains controversial which type of self-expandable metal stent (SEMS) is the most suitable for patients with resectable/borderline resectable pancreatic cancer during NAC/NACRT: an uncovered SEMS (USEMS), a fully covered SEMS (FCSEMS) or a partially covered SEMS (PCSEMS).
View Article and Find Full Text PDFBackground: The clinical characteristics of IgG4-related sclerosing cholangitis (IgG4-SC) especially without autoimmune pancreatitis (AIP) have not been investigated in a large cohort.
Aims: To clarify the clinical characteristics of IgG4-SC and IgG4-SC without AIP.
Methods: We retrospectively reviewed imaging, serology, other organ involvement (OOI) and histology of 872 patients with IgG4-SC who participated in a Japanese nationwide survey in 2019, and compared these items between IgG4-SC with and without AIP.
Cancers (Basel)
February 2021
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.
Backround: Not all patients with hepatocellular carcinoma (HCC) benefit from treatment with molecular targeted agents such as sorafenib. We investigated whether New-FP (fine-powder cisplatin and 5-fluorouracil), a hepatic arterial infusion chemotherapy regimen, is more favorable than sorafenib as an initial treatment for locally progressed HCC.
Methods: To avoid selection bias, we corrected the data from different facilities that did or did not perform New-FP therapy.
J Toxicol Sci
September 2020
Oncology Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University.
Information on the safety of chemical substances in patients with various preexisting conditions remains limited. Acetaminophen was added to the basal diet at 0, 80, 253, 800, 2530, or 8000 ppm and administered to type 2 diabetes mellitus rats (GK/Jcl) and the control male rats (Wistar) for 13 weeks. Both strains treated with 8000 ppm acetaminophen (561.
View Article and Find Full Text PDFNihon Shokakibyo Gakkai Zasshi
January 2019
Department of Gastroenterology, IMS Sapporo Digestive Disease Center General Hospital.
Surg Today
March 2016
Department of Surgery, Teine-Keijinkai Hospital, 1-jo 12-chome, Maeda, Teine-ku, Sapporo, Hokkaido, 006-8555, Japan.
Purpose: To minimize the parietal trauma associated with multiple surgical access sites, single-incision laparoscopic surgery for colectomy has been emerging with the improvements in instrumentation and surgical techniques. The purpose of this study was to compare the clinicopathological outcomes between single-incision laparoscopic right colectomy (SILC) and multiport laparoscopic right colectomy (MLC) for right colon cancer.
Methods: Thirty-five consecutive patients undergoing SILC from a prospective single-institution database were case matched according to demographic data to an equivalent number of patients who underwent MLC.